Updates from The Motley Fool

Latest updates on Theravance, Inc. from Fool.com.

Stock Performance

THRX vs. S&P 500 | 2 Year Performance
THRX 1-Day Stock Chart
THRX 5-Day Stock Chart
THRX 1-Month Stock Chart
THRX 3-Month Stock Chart
THRX 6-Month Stock Chart
THRX 1-Year Stock Chart
THRX 2-Year Stock Chart
THRX 5-Year Stock Chart
View Interactive THRX Charts
Sponsored by

Key Data Points

Primary metrics and data points about Theravance, Inc..
Current Price: $0.00
Prev Close: $0.00
Open: $0.00
Bid: $0.00
Ask: $0.00
Day's Range: $0.00 - $0.00
52wk Range: $0.00 - $0.00
Volume: 0
Avg Vol 0
Market Cap: $0.00
P/E (ttm): 0.00
EPS (ttm): $0.00
Div & Yield: $1.00 (10.2%)

CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Rick E. Winningham, CEO

78% Approve

Based on 6 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Theravance, Inc..

A biopharmaceutical company focuses on the discovery, development and commercialization of small molecule medicines across a number of therapeutic areas including respiratory disease, bacterial infections and gastrointestinal motility dysfunction.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers